L2L Microarray Analysis Tool
Results for J01AA.profile.d50
| Results summary | View all lists in L2L MDB | View all genes in J01AA.profile.d50 |
| List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
|---|---|---|---|---|---|---|
| uvc_ttd_all_dn | Down-regulated at any timepoint following treatment of XPB/TTD fibroblasts with 3 J/m^2 UVC | 780 | 1.93 | 10 | 5.19 | 3.31e-05 |
| uvc_ttd_4hr_dn | Down-regulated at 4 hours following treatment of XPB/TTD fibroblasts with 3 J/m^2 UVC | 641 | 1.58 | 9 | 5.68 | 4.06e-05 |
| uvc_ttd-xpcs_common_dn | Down-regulated at any timepoint following treatment of both XPB/CS and XPB/TTD fibroblasts with 3 J/m^2 UVC | 344 | 0.85 | 6 | 7.06 | 2.47e-04 |
| gh_exogenous_early_dn | Down-regulated at early time points (1-4 hours) following treatment of mammary carcinoma cells (MCF-7) with exogenous human growth hormone | 14 | 0.03 | 2 | 57.79 | 5.45e-04 |
| vhl_rcc_up | Upregulated in VHL-null renal carcinoma cells vs. VHL-rescued (Fig. 1a+b) | 153 | 0.38 | 4 | 10.58 | 6.11e-04 |
| uvc_xpcs_all_dn | Down-regulated at any timepoint following treatment of XPB/CS fibroblasts with 3 J/m^2 UVC | 1048 | 2.59 | 9 | 3.47 | 1.43e-03 |
| vegf_huvec_up | 20 genes with the largest fold-change up-regulation at any time point (30min to 24 hours) after VEGF treatment in human umbilical vein endothelial cells | 24 | 0.06 | 2 | 33.71 | 1.63e-03 |
| 5azac-tsa_hepg2_dn | Down-regulated in human hepatoma cells (HepG2) following 24 hrs treatment with 2.5 microM 5-aza-2-deoxycytidine (5azaC) and 24 hrs treatment with both 5azaC and 500 nM trichostatin A (TSA). | 2343 | 5.79 | 14 | 2.42 | 2.63e-03 |
| tgfb_hmvec_2hr_up | Up-regulated 2 hr following treatment of human microvessel endothelial cells (HMVEC) with TGFbeta. | 1997 | 4.94 | 12 | 2.43 | 4.89e-03 |
| tgfb_hmvec_4hr_up | Up-regulated 4 hr following treatment of human microvessel endothelial cells (HMVEC) with TGFbeta. | 1997 | 4.94 | 12 | 2.43 | 4.89e-03 |
| gh_exogenous_any_dn | Down-regulated at any time point (1-24 hours) following treatment of mammary carcinoma cells (MCF-7) with exogenous human growth hormone | 142 | 0.35 | 3 | 8.55 | 5.46e-03 |
| uvc_xpcs_8hr_dn | Down-regulated at 8 hours following treatment of XPB/CS fibroblasts with 3 J/m^2 UVC | 911 | 2.25 | 7 | 3.11 | 8.32e-03 |